The Global Recombinant Proteins Market Research Report is a valuable source of knowledgeable data for business strategies and methodologies. The study provides the overall industry overview along with the growth trends, past and futuristic cost, revenue, demand, sales, and the supply data. A detailed description of the industry value chain, as well as the distributor analysis, has been provided by the industry specialists. The market report also provides wide-ranging data, which further enhances the understanding, scope, and applications of the report.
The global recombinant proteins market is projected to reach USD 1.7 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 9.8% during the forecast period. Market growth is largely driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics. The emerging Asian countries are also expected to offer strong growth opportunities for players in the recombinant proteins market.
Request a Sample Copy of Recombinant Proteins Market: https://www.marketsandmarkets.com/requestsampleNew.asp?id=70095015
Some of the key players operating in the Recombinant Proteins Market are as follows:
Thermo Fisher Scientific, Inc. (US), Miltenyi Biotech (Germany), Sino Biological Inc. (China), Merck KGaA (Germany), Abcam plc (UK), Biolegend (US), Bio-Rad Laboratories, Inc. (US), GenScript Biotech Corporation (China), Enzo Life Sciences, Inc. (US), BPS Bioscience, Inc. (US), PeproTech, Inc. (US), Proteintech Group, Inc. (US), Abnova Corporation (Taiwan), R&D Systems (US), STEMCELL Technologies Inc (Canada), RayBiotech Inc (US), CellGenix GmbH (Germany), ACROBiosystems (US), ProSpec-TechnoGene Ltd. (Israel), Neuromics (US), RICHCORE LIFESCIENCES PVT LTD (India), Icosagen AS (US), ProteoGenix (France), United States Biological (US), StressMarq Biosciences Inc (Canada), and Aviva Systems Biology Corporation (US) and Among Others
These players are forecast to maintain their strong market shares throughout the forecast period.
Study Goals and Objectives:
The aim of this report is to:
- Study of the statistics on the frequency and mortality of the disease.
- Present an evaluation of the different types of resilient and therapeutic types of the disease.
- Provide an understanding of the mechanisms of resistant and relapse in the disease.
The major objectives of this research study are to conduct and provide an in-depth analysis of the market growth rates, value, size, shares, and market development as well as the market dynamics and market factors affecting the growth and progression of the Recombinant Proteins Market. This report also considers the hindrances and the potential threats concerning the major market suppliers as well as the drug manufacturers in the local and regional markets.
Download a PDF Copy: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=70095015
This report categorizes the recombinant proteins market into the following segments and subsegments:
By Product
- Growth Factors and Chemokines
- Immune Response Proteins
- Structural Proteins
- Membrane Proteins
- Kinase Proteins
- Regulatory Proteins
- Recombinant Metabolic Enzymes
- Adhesion Molecules and Receptors
- Other Recombinant Proteins (include viral antigens and other proteins that participate in the vital cellular role of cell migration, survival, and regulation of immune responses to apoptosis, Alzheimer’s disease, tumor cell phenotypes, neuroinflammation, and autoimmune diseases)
By Application
- Drug Discovery & Development
- Biologics
- Vaccines
- Cell & Gene Therapy
- Biopharmaceutical Production
- Biotechnology Research
- Academic Research Studies
- Other Applications (diagnostics, forensic, and cosmetology applications)
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Other End Users [diagnostic centers, laboratories (hospital-attached laboratories (HALs) and independent diagnostic laboratories), forensic laboratories, and the cosmetic industry]
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Rest of the World
Reasons to Buy:
- Comprehend the current clinical and commercial scenario in view of the disease pathogenesis, identification, detection, diagnosis, and the treatment options available at each stage of the disease.
- Envision the composition of the Recombinant Proteins Market, in terms of dynamic molecule types and targets, underlining the major industry resources and players.
- Analyze the product pipeline and study by stage of the disease, molecule target, with a granulated breakdown across key symptoms.
- Understand the growth in patient epidemiology and market revenue for the market globally and across the key players and market segments.
- Study the market in terms of the generic and premium product revenue.
- Determine commercial opportunities in the Recombinant Proteins Market sakes scenario by analyzing trends in authorizing and co-development deals.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road, Suite 430, Northbrook, IL 60062
USA: 1-888-600-6441